D. Altman, Y. Vergouwe, P. Royston, and K. Moons. BMJ (Clinical research ed.), (January 2009)5171<br/>GR: Cancer Research UK/United Kingdom; GR: Medical Research Council/United Kingdom; JID: 8900488; epublish;<br/><br/>Models predictius; Avaluació de riscs.
K. Moons, D. Altman, Y. Vergouwe, and P. Royston. BMJ (Clinical research ed.), (January 2009)5180<m:linebreak></m:linebreak>GR: Cancer Research UK/United Kingdom; GR: Medical Research Council/United Kingdom; JID: 8900488; epublish;<m:linebreak></m:linebreak>Avaluació de riscs.
S. Fieuws, and G. Verbeke. Statistics in medicine, 23 (20):
3093-104(October 2004)4302<m:linebreak></m:linebreak>PUBM: Print; CI: Copyright 2004; JID: 8215016; ppublish;<m:linebreak></m:linebreak>Mixed models.
L. Inoue, R. Gulati, C. Yu, M. Kattan, and R. Etzioni. Biostatistics (Oxford, England), 14 (1):
15-27(January 2013)7099<m:linebreak></m:linebreak>JID: 100897327; 2012/06/22 aheadofprint; aheadofprint; Bona gràfica per explicar els lead times segons el moment del diagnòstic.
D. Altman, L. McShane, W. Sauerbrei, and S. Taube. PLoS medicine, 9 (5):
e1001216(January 2012)6692<m:linebreak></m:linebreak>M3: doi:10.1371/journal.pmed.1001216;<m:linebreak></m:linebreak>Publicació.